老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Kailera Therapeutics, Inc.
12.70
-0.7500
-5.58%
成交量：
113.49萬
成交額：
1,464.34萬
市值：
16.45億
市盈率：
-5.63
高：
13.68
開：
13.55
低：
12.47
收：
13.45
52周最高：
28.23
52周最低：
12.47
股本：
1.30億
流通股本：
4,492.19萬
量比：
1.49
換手率：
2.53%
股息：
- -
股息率：
- -
每股收益(TTM):
-2.2543
每股收益(LYR):
-7,819.9811
淨資產收益率：
-36.90%
總資產收益率：
-22.73%
市淨率：
1.47
市盈率(LYR):
0.00
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字：
Kailera Therapeutics, Inc.
交易所：
NASDAQ
成立時間：
2024
員工人數：
- -
公司地址：
180 Third Avenue,4th Floor,Waltham,Massachusetts,United States
官網：
http://www.kailera.com
郵編：
02451
電話：
781 317 0290
傳真：
- -
簡介：
Kailera Therapeutics, Inc.於2024年5月8日根據特拉華州法律註冊成立。該公司是一家處於臨床階段的生物技術公司，致力於通過推進多元化的研發管線，引領肥胖症治療的新時代。目前，該公司正在快速推進四款處於臨床階段的候選產品，這些產品利用多種基於胰高血糖素樣肽-1 (GLP-1) 的作用機制和給藥途徑。
董事
名稱
職位
John F. Milligan
Chairman and Director
Ronald C. Renaud, Jr.
Chief Executive Officer,Director and President
Adam Koppel
Independent Director
Andrew Kaplan
Independent Director
Christopher Hite
Independent Director
Frank Clyburn, Jr.
Independent Director
Martin Mackay
Independent Director
Michael Gladstone
Independent Director
Yuting Liu
Independent Director
股東
名稱
職位
Ronald C. Renaud, Jr.
Chief Executive Officer,Director and President
Paul Burgess
Chief Business Officer and Chief Operating Officer
Douglas Pagán
Chief Financial Officer
Jamie Coleman
Chief Commercial Officer
Paula Cloghessy
Chief People Officer
Scott Akamine
Chief Legal Officer and Secretary
Scott Wasserman
Chief Medical Officer
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/KLRA/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"KLRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KLRA\",,,,,undefined,":{"symbol":"KLRA","market":"US","secType":"STK","nameCN":"Kailera Therapeutics, Inc.","latestPrice":12.7,"timestamp":1789588800000,"preClose":13.45,"halted":0,"volume":1134934,"delay":0,"changeRate":-0.05576208178438662,"floatShares":44921899,"shares":129537300,"eps":-2.254252,"marketStatus":"盤前交易","change":-0.75,"latestTime":"09-17 05:26:09 EDT","open":13.55,"high":13.675,"low":12.47,"amount":14643432.593101999,"amplitude":0.089591,"askPrice":17.36,"askSize":100,"bidPrice":11.66,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.254252,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789651800000},"marketStatusCode":1,"adr":0,"listingDate":1776398400000,"exchange":"NASDAQ","adjPreClose":12.7,"postHourTrading":{"tag":"盘后","latestPrice":12.75,"preClose":12.7,"latestTime":"19:30 EDT","volume":5486,"amount":69722.82,"timestamp":1789601405784,"change":0.05,"changeRate":0.003937,"amplitude":0.017323},"volumeRatio":1.485620711742133},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KLRA\",,,,,undefined,":{"symbol":"KLRA","floatShares":44921899,"roa":"-22.73%","roe":"-36.90%","lyrEps":-7819.9811,"volumeRatio":1.485620711742133,"shares":129537300,"dividePrice":0,"high":13.675,"amplitude":0.089591,"preClose":13.45,"low":12.47,"week52Low":12.47,"pbRate":"1.47","week52High":28.2271,"institutionHeld":0,"latestPrice":12.7,"eps":-2.254252,"divideRate":0,"volume":1134934,"delay":0,"ttmEps":-2.254252,"open":13.55,"prevYearClose":16,"prevWeekClose":13.94,"prevMonthClose":15.4,"prevQuarterClose":22.03,"fiveDayClose":14.84,"twentyDayClose":17.83,"sixtyDayClose":22.88},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KLRA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"KLRA","fiscalQuarterEnding":"2026/06","expectedEps":-0.74,"name":null,"time":"盤後","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-1.09}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KLRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KLRA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":6,"updateTime":1783483200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KLRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KLRA","date":"2026-09-16","current":-5.633798,"percent":1,"low":-21.871461,"twenty":-19.406899,"median":-13.380322,"eighty":-8.206413,"high":-5.967575,"avg":-14.086608,"sd":4.909316,"marketCap":1743707442},"quantilePoints":[{"date":"2026-04-17","current":-12.669466,"twenty":-12.511098,"median":-12.273546,"eighty":-12.035993,"marketCap":1887180368},{"date":"2026-04-24","current":-20.824025,"twenty":-20.917019,"median":-20.433783,"eighty":-14.17085,"marketCap":3101842710},{"date":"2026-05-01","current":-21.741015,"twenty":-21.413894,"median":-20.305085,"eighty":-18.829635,"marketCap":3238432850},{"date":"2026-05-08","current":-19.540824,"twenty":-21.576784,"median":-20.824025,"eighty":-19.524523,"marketCap":2910703445},{"date":"2026-05-15","current":-18.697273,"twenty":-21.521865,"median":-20.058623,"eighty":-18.676401,"marketCap":2785052251},{"date":"2026-05-22","current":-18.332024,"twenty":-21.403595,"median":-19.540824,"eighty":-18.304195,"marketCap":2730646579},{"date":"2026-05-29","current":-19.949555,"twenty":-21.097481,"median":-19.520448,"eighty":-18.332024,"marketCap":2971585983},{"date":"2026-06-05","current":-18.253756,"twenty":-20.940268,"median":-19.530636,"eighty":-18.332024,"marketCap":2718988220},{"date":"2026-06-12","current":-16.992777,"twenty":-20.824025,"median":-19.392985,"eighty":-17.13192,"marketCap":2531159115},{"date":"2026-06-18","current":-16.636224,"twenty":-20.511831,"median":-18.758148,"eighty":-17.050173,"marketCap":2478048816},{"date":"2026-06-26","current":-12.75669,"twenty":-20.227867,"median":-18.684228,"eighty":-17.050173,"marketCap":2676825461},{"date":"2026-07-02","current":-12.855483,"twenty":-20.165517,"median":-18.622605,"eighty":-16.764931,"marketCap":2697555958},{"date":"2026-07-10","current":-12.9728,"twenty":-20.033041,"median":-18.410291,"eighty":-15.433812,"marketCap":2722173424},{"date":"2026-07-17","current":-11.311837,"twenty":-19.949555,"median":-18.314631,"eighty":-13.521103,"marketCap":2373641938},{"date":"2026-07-24","current":-10.743775,"twenty":-19.944337,"median":-17.453687,"eighty":-12.859187,"marketCap":2254441579},{"date":"2026-07-31","current":-10.527665,"twenty":-19.923466,"median":-17.13192,"eighty":-12.704356,"marketCap":2209093616},{"date":"2026-08-07","current":-11.651439,"twenty":-19.849563,"median":-17.071044,"eighty":-11.79378,"marketCap":2444903022},{"date":"2026-08-14","current":-7.973035,"twenty":-19.724778,"median":-16.992777,"eighty":-11.573639,"marketCap":2329696857},{"date":"2026-08-21","current":-7.746755,"twenty":-19.603438,"median":-16.640572,"eighty":-11.334065,"marketCap":2263578582},{"date":"2026-08-28","current":-8.221499,"twenty":-19.532674,"median":-16.131833,"eighty":-11.014222,"marketCap":2402297316},{"date":"2026-09-04","current":-6.983615,"twenty":-19.497291,"median":-13.667441,"eighty":-10.594351,"marketCap":2040591460},{"date":"2026-09-11","current":-6.615356,"twenty":-19.448642,"median":-13.506901,"eighty":-10.353542,"marketCap":1932987209},{"date":"2026-09-16","current":-5.967575,"twenty":-19.406899,"median":-13.380322,"eighty":-8.206413,"marketCap":1743707442}],"updateTime":1789637169740},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1899116257,"yearFounded":2024,"address":"180 Third Avenue,4th Floor,Waltham,Massachusetts,United States","zipCode":"02451","officePhone":"781 317 0290","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.kailera.com","stockEarnings":[{"period":"1week","weight":-0.1442},{"period":"1month","weight":-0.3139},{"period":"3month","weight":-0.3618},{"period":"6month","weight":-0.2063},{"period":"ytd","weight":-0.2063}],"compareEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":-0.0241},{"period":"3month","weight":0.0098},{"period":"6month","weight":0.1626},{"period":"1year","weight":0.1425},{"period":"ytd","weight":0.1058}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Kailera Therapeutics, Inc.於2024年5月8日根據特拉華州法律註冊成立。該公司是一家處於臨床階段的生物技術公司，致力於通過推進多元化的研發管線，引領肥胖症治療的新時代。目前，該公司正在快速推進四款處於臨床階段的候選產品，這些產品利用多種基於胰高血糖素樣肽-1 (GLP-1) 的作用機制和給藥途徑。","exchange":"NASDAQ","name":"Kailera Therapeutics, Inc.","nameEN":"Kailera Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"KLRA\",market:\"US\",,,undefined,":{"directors":[{"name":"John F. Milligan","position":"Chairman and Director"},{"name":"Ronald C. Renaud, Jr.","position":"Chief Executive Officer,Director and President"},{"name":"Adam Koppel","position":"Independent Director"},{"name":"Andrew Kaplan","position":"Independent Director"},{"name":"Christopher Hite","position":"Independent Director"},{"name":"Frank Clyburn, Jr.","position":"Independent Director"},{"name":"Martin Mackay","position":"Independent Director"},{"name":"Michael Gladstone","position":"Independent Director"},{"name":"Yuting Liu","position":"Independent Director"}],"executives":[{"name":"Ronald C. Renaud, Jr.","position":"Chief Executive Officer,Director and President"},{"name":"Paul Burgess","position":"Chief Business Officer and Chief Operating Officer"},{"name":"Douglas Pagán","position":"Chief Financial Officer"},{"name":"Jamie Coleman","position":"Chief Commercial Officer"},{"name":"Paula Cloghessy","position":"Chief People Officer"},{"name":"Scott Akamine","position":"Chief Legal Officer and Secretary"},{"name":"Scott Wasserman","position":"Chief Medical Officer"}]}}}